Cori disease, cardiac involvement in, 1088–1089 Coronary angiography, Kawasaki syndrome and, 987, 988f Coronary arteries anatomy of, 30–31, 30f–31f aneurysms of, in Kawasaki syndrome, 983–984 teachings for, 993–994 anomalous origin of, 318t repair of, exercise testing following, 400 anomalous aortic origin of, 865–867, 868f, 873–875, 873f cardiopulmonary exercise stress testing of, 874 clinical presentation of, 873 computed tomographic angiography and magnetic resonance imaging of, 874 diagnostic testing of, 873–874 echocardiography of, 873–874, 874f outcomes for, 875 pathophysiology of, 873 surgical intervention for, 874–875 surgical techniques for, 875 arterial switch procedures and, 688–689, 689f, 693–694, 693f in diagnostic catheterization, 250–251 duplication of, 867 ectopic origin of, 865, 866f–867f left, anatomy of, 30, 31f right anatomy of, 30 dominance of, 30, 30f single, 875 solitary, 867–868, 869f thrombosis of, in Kawasaki syndrome prevention of, 990–991 treatment of, 990t, 991 in transposition of the great arteries, 676–677, 678f–679f Coronary arterio-venous fistulas clinical features of, 937–938 investigations in, 938–940, 939f–940f long-term outcomes of, 941–944, 942f–943f management of, 940–941, 941f morphology of, 936–937, 937f–938f Coronary artery abnormalities, classifications of, 986t fistulae of, 99–100 flow in, fetal, 95, 95f Coronary circulation, endothelial function in, 1367 Coronary orificial atresia, 875–876 clinical presentation of, 875 diagnostic testing of, 875–876 outcomes for, 876 pathophysiology of, 875 surgical technique for, 876 Coronary sinus septal defect, in diagnostic catheterization, 246 Coronary sinuses absence of, with isomeric atrial appendages, 441 anomalies of, 465f, 470, 470f defects of, 506–507, 507f–508f facing, 30, 30f left superior caval vein to, 462, 462f Coronary veins, anatomy of, 31–32, 31f Correlation coefficient, 414 Corticosteroids in cardiopulmonary bypass, 231–232 for Kawasaki syndrome, 989 for myocarditis, 1177 Counseling for congenital heart disease, 163 initial session of, 167–168 style of, recommended, 163 preconception, with congenital heart disease, 1442 during transition, 1453 CPB, Cardiopulmonary bypass CPET, Cardiopulmonary exercise testing CPVT, Catecholaminergic polymorphic ventricular tachycardia C-reactive protein in rheumatic fever, 1013 systemic arterial dysfunction and, 1371 Credibility, 1488–1493 CRISPR/Cas9 technology, 82 Criss-cross hearts, 920–926, 920f–926f Crista dividens, 86, 86f Critical heart diseases, in neonates, 1523, 1523t Cross-sectional imaging, 285–286 fetal, 126 Cross-sectional studies, 417 CRT, Cardiac resynchronization therapy CTC, Cancer therapy-related cardiotoxicity C-type natriuretic peptide, 1358 Cumulative mortality chart, monitored interstage mortality using, 1507–1509, 1508f Currarino-Silverman syndrome, 913–914 Current data environment, 403 Cushing syndrome, hypertension in, 1136 Cusp, 945 Cutis laxa, cardiac involvement in, 1098 Cyanosis, in tetralogy of Fallot, 638–639 Cyanotic cardiac disease in pregnancy, 1446 Cycle ergometers, 388 protocols, 388, 389f